Omega-3 fatty acids for proteinuria due to nephrotic syndrome a review of clinical effectiveness and cost-effectiveness

The purpose of this review is to assess the clinical and cost-effectiveness of n-3 fatty acid supplementation for the reduction of proteinuria in patients with nephrotic syndrome

Bibliographic Details
Corporate Authors: Canadian Agency for Drugs and Technologies in Health, Canadian Agency for Drugs and Technologies in Health Rapid Response Service
Format: eBook
Language:English
Published: Ottawa (ON) CADTH Rapid Response Service 2016, 05 February 2016
Series:Rapid response report: summary with critical appraisal
Subjects:
Online Access:
Collection: National Center for Biotechnology Information - Collection details see MPG.ReNa
Description
Summary:The purpose of this review is to assess the clinical and cost-effectiveness of n-3 fatty acid supplementation for the reduction of proteinuria in patients with nephrotic syndrome
Physical Description:1 PDF file (29 pages) illustration